Compliance updated on Jun 19, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor

Financial data updated nightly

Malin Corporation PLC

MLC.I ✗ NOT COMPLIANT ☆ Track — members

Euronext Dublin / ISE · Healthcare · Pharmaceuticals ·

Ireland Micro Cap Analyst: BUY

Last Close

$8.16

▲ +0.00%

Market Cap $36.04M · Vol 2

Key Metrics

P/E Ratio

N/A

FWD: N/A

Market Cap

$36.04M

Micro Cap

Div Yield

N/A

EPS Growth

N/A

YoY

RSI (14)

20.00

Momentum

Beta

0.21

vs Market

52W High

$10.85

25.44% below

52W Low

$7.93

4.15% above

Volume

Avg 134

P/B

0.84

Price-to-book

ROE

N/A

Return on equity

Free Float

65.04%

Public shares

Shariah Compliance8 STANDARDS

✗ Malin Corporation PLC (MLC.I) stock is currently not Shariah compliant

AAOIFI—
Dow Jones Islamic (DJIM)—
FTSE Shariah—
MSCI Islamic—
S&P Shariah—
Al Rajhi—
Alinma—
Albilad—

Unlock the full Shariah report

See which standards it fails, the exact ratios behind the verdict, and halal alternatives. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does MLC.I pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns

+0.00%

-1.41%

-7.89%

YTD

-9.09%

-12.50%

+64.32%

+0.00%

Financials & Valuation

TTM · Annual

Total Revenue	$0.00
Net Income	$0.00
Revenue Growth (YoY)	N/A
Gross Margin	N/A
Operating Margin	N/A
Net Profit Margin	N/A
ROE	N/A
ROA · ROIC	0.00% · N/A

P/E Ratio	N/A
Forward P/E (FY1)	N/A
PEG Ratio	N/A
P/S	N/A
P/B	0.84
P/FCF	N/A
EPS Growth	N/A
Outstanding Shares	4.33M

Technical Indicators

50-Day SMA	$8.36
200-Day SMA	$8.92
RSI (14)	20.00
Beta	0.21
52-Week High	$10.85
52-Week Low	$7.93

Volume Today	2
Avg Daily Volume (30D)	134
Relative Volume	0.01x
Volatility (10D)	5.07
Volatility (30D)	7.10
Free Float	65.04%

Analyst Consensus

BUY

Current Price $8.16

Mean Target N/A

52W Low$7.93 52W High$10.85

Current

Target

$7.93 $10.85

Current Analyst target

· 0 analysts

Identifiers

ExchangeEuronext Dublin / ISE

FIGIBBG0087MPRF3

ISINIE00BVGC3741

CountryIreland

Sub-IndustryPharmaceuticals (NEC)

Earnings DateN/A

TypeStocks

Instrument TypeORD Ordinary Share

Similar Halal Stocks

LLY Eli Lilly and Co -0.67% JNJ Johnson & Johnson +1.04% ABBV Abbvie Inc -0.17% NVS Novartis AG -0.53% NOVN.S Novartis AG -0.52%

Company Profile

Malin Corporation PLC is focused on investing in life sciences companies. The Company’s assets give investors access to life sciences businesses with exposure across diverse modalities, therapeutic areas and geographies. Its business includes Poseida, Viamet, Xenex, WaveBreak, KNOW Bio, and Artizan. Poseida is a clinical-stage biopharmaceutical company building a pipeline of Chimeric antigen receptor T cell (CAR-T) product candidates. Xenex is a commercial-stage medical device company focused on reducing healthcare-associated infections with its non-mercury, full-spectrum disinfection LightStrike Germ-Zapping robots. KNOW Bio is a life science company engaged in the fields of nitric oxide and precision light therapy. WaveBreak Therapeutics company focuses on the development of medicines for the treatment of protein-misfolding diseases including Alzheimer's and Parkinson's. Artizan is a biotechnology company.